Related Experiment Video
Updated: Jun 2, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Inhibition of Kir2.1 (KCNJ2) by the AMP-activated protein kinase
Ioana Alesutan1, Carlos Munoz, Mentor Sopjani
1Department of Physiology, University of Tübingen, Gmelinstrasse 5, Tübingen, Germany.
Abstract:
The inward rectifier K(+) channel Kir2.1 participates in the maintenance of the cell membrane potential in a variety of cells including neurons and cardiac myocytes. Mutations of KCNJ2 encoding Kir2.1 underlie the Andersen-Tawil syndrome, a rare disorder clinically characterized by periodic paralysis, cardiac arrhythmia and skeletal abnormalities. The maintenance of the cardiac cell membrane potential is decreased in ischaemia, which is known to stimulate the AMP-activated serine/threonine protein kinase (AMPK). This energy-sensing kinase stimulates energy production and limits energy utilization. The present study explored whether AMPK regulates Kir2.1. To this end, cRNA encoding Kir2.1 was injected into Xenopus oocytes with and without additional injection of wild type AMPK (AMPKα1+AMPKβ1+AMPKγ1), of the constitutively active (γR70Q)AMPK (α1β1γ1(R70Q)), of the kinase dead mutant (αK45R)AMPK (α1(K45R)β1γ1), or of the ubiquitin ligase Nedd4-2. Kir2.1 activity was determined in two-electrode voltage-clamp experiments. Moreover, Kir2.1 protein abundance in the cell membrane was determined by immunostaining and subsequent confocal imaging. As a result, wild type and constitutively active AMPK significantly reduced Kir2.1-mediated currents and Kir2.1 protein abundance in the cell membrane. Expression of wild type Nedd4-2 or of Nedd4-2(S795A) lacking an AMPK phosphorylation consensus sequence downregulated Kir2.1 currents. The effect of wild type Nedd4-2 but not of Nedd4-2(S795A) was significantly augmented by additional coexpression of AMPK. In conclusion, AMPK is a potent regulator of Kir2.1. AMPK is at least partially effective through phosphorylation of the ubiquitin ligase Nedd4-2.
Insights
The AMP-activated protein kinase (AMPK) regulates the Kir2.1 potassium channel, impacting cell membrane potential. AMPK reduces Kir2.1 activity and cell membrane levels, partly via Nedd4-2 phosphorylation.
Area of Science:
- Physiology
- Molecular Biology
- Biochemistry
Background:
- The inward rectifier potassium channel Kir2.1 is crucial for maintaining cell membrane potential in neurons and cardiac myocytes.
- Mutations in KCNJ2, encoding Kir2.1, cause Andersen-Tawil syndrome, characterized by periodic paralysis, cardiac arrhythmia, and skeletal abnormalities.
- Ischemia decreases cardiac cell membrane potential and activates AMP-activated serine/threonine protein kinase (AMPK), an energy-sensing kinase.
Purpose of the Study:
- To investigate whether AMPK regulates the function and abundance of the Kir2.1 channel.
- To explore the molecular mechanisms underlying AMPK's regulation of Kir2.1.
Main Methods:
- Xenopus oocytes were injected with cRNA encoding Kir2.1, along with various forms of AMPK or the ubiquitin ligase Nedd4-2.
- Kir2.1 activity was measured using two-electrode voltage-clamp experiments.
- Kir2.1 protein levels in the cell membrane were quantified via immunostaining and confocal imaging.
Main Results:
- Both wild-type and constitutively active AMPK significantly decreased Kir2.1-mediated currents and Kir2.1 protein abundance in the cell membrane.
- Nedd4-2 expression downregulated Kir2.1 currents, an effect potentiated by co-expressed AMPK.
- Nedd4-2(S795A), a mutant lacking an AMPK phosphorylation site, showed reduced downregulation of Kir2.1 currents compared to wild-type Nedd4-2 when co-expressed with AMPK.
Conclusions:
- AMPK is a significant regulator of Kir2.1 channel activity and membrane expression.
- AMPK's regulatory effect on Kir2.1 is, at least partly, mediated through the phosphorylation of the ubiquitin ligase Nedd4-2.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
G-Protein Gated Ion Channels
Sensory organs,...
Inhibition of CDK Activity
Inhibition of Cdk Activity
Ligand-Gated Ion Channel Receptor: Gating Mechanism
PI3K/mTOR/AKT Signaling Pathway

